Difficulty: Medium
Average Score: 72%
Practice
A 56-year-old male is on numerous medications, many of which are metabolized by the cytochrome P-450 system. He went to the psychiatric with depression. Given his multiple medications, which of the following antidepressant drugs should be avoided?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Fluoxetine, which should be avoided in the 56-year-old male due to its significant interactions with the cytochrome P-450 system. Fluoxetine is a potent inhibitor of CYP2D6, a major enzyme involved in drug metabolism, leading to potential drug interactions and increased levels of medications metabolized by this pathway.
Citalopram (Option B) and Sertraline (Option C) are both selective serotonin reuptake inhibitors (SSRIs) that have a lower risk of interactions with the cytochrome P-450 system compared to Fluoxetine. Imipramine (Option D) is a tricyclic antidepressant that is metabolized by different enzymes and does not pose the same risk of interactions with the cytochrome P-450 system as Fluoxetine.
Educationally, it is crucial for healthcare professionals to understand the pharmacokinetic profiles of different medications, especially in patients on multiple drugs. This knowledge helps in making informed decisions to avoid harmful drug interactions and ensure optimal therapeutic outcomes for patients. Understanding the metabolic pathways of drugs can prevent adverse effects and improve patient safety and treatment efficacy.
Citalopram (Option B) and Sertraline (Option C) are both selective serotonin reuptake inhibitors (SSRIs) that have a lower risk of interactions with the cytochrome P-450 system compared to Fluoxetine. Imipramine (Option D) is a tricyclic antidepressant that is metabolized by different enzymes and does not pose the same risk of interactions with the cytochrome P-450 system as Fluoxetine.
Educationally, it is crucial for healthcare professionals to understand the pharmacokinetic profiles of different medications, especially in patients on multiple drugs. This knowledge helps in making informed decisions to avoid harmful drug interactions and ensure optimal therapeutic outcomes for patients. Understanding the metabolic pathways of drugs can prevent adverse effects and improve patient safety and treatment efficacy.